WARREN, N.J.—Mondottica USA has announced a multi-year licensing agreement for the design, production and distribution of Roxy prescription frames and prescription sunglasses in the optical channel in the U.S., Latin America and the Caribbean. This announcement follows Mondottica USA’s recent partnership with Boardriders and the upcoming summer launch of Quiksilver prescription frames and prescription sunglasses, as reported in VMAIL. As an extension of the long-term strategy of Mondottica USA, the alliance with Boardriders has brought welcomed additions of active lifestyle brands with strong consumer appeal in the U.S. and Latin America.

Roxy will launch in Spring 2023 with 18 women’s optical styles and 6 women’s polarized prescription sun styles. Youth styles will follow for the back-to-school season.

CEO of Mondottica USA, Ken Liming, said, “We are very excited to announce the addition of the iconic Roxy brand into our portfolio. Roxy is the original action sport brand for women and our goal is to carry the brand’s essence into the optical world by making the consumer feel feminine, natural, alive and connected to the beach and mountain way of life. We welcome this collection into our diverse portfolio and as a sister lifestyle brand to our men’s Quiksilver line.”

David Brooks, Boardriders’ global GM of partnership and distribution, said, “We are excited to continue and extend our relationship with Mondottica USA to develop a collection of prescription eyewear for our Roxy brand.”